CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Non-obstructive High-Risk Plaques Increase the Risk of Future Culprit Lesions Comparable to Obstructive Plaques Without High-Risk Features: The ICONIC Study The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction

Guideline31 August 2019

JOURNAL:Eur Heart J. Article Link

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines

F Cosentino, PJ Grant, ESC Scientific Document Group et al. Keywords: guidelines; diabetes mellitus; impaired glucose tolerance; cardiovascular diseases; epidemiology; risk factors; prevention; cardiovascular risk assessment; patient management; pharmacological treatment; revascularization; patient-centred care

FULL TEXT PDF